Making Partnerships Work for All: The SPARC Metastatic Breast Cancer Challenge Example
نویسندگان
چکیده
منابع مشابه
Making It All Work
The greater prevalence of type 2 diabetes is a critical issue among the U.S. Hispanic population. This study examined the struggles of Hispanic adults managing type 2 diabetes with limited resources. Ten Hispanic adults (enrolled in a larger study to determine the effects of diabetes self-management intervention), 25 to 80 years of age and living in a rural West Texas county in the United State...
متن کاملTaking charge: making partnerships work for better health outcomes.
The ambitious goal of eliminating racial and ethnic disparities in health care will require a strong message, creative approaches and close collaboration by public and private partners across the health system, Dr. James Gavin, new president of Morehouse School of Medicine, told the audience at the closing session of the Primary Care Conference. The goal cannot be reached without ‘‘a concerted ...
متن کاملClinicopathological Features of Non-metastatic Triple Negative Breast Cancer
Background: Triple negative breast cancer (TNBC) is reported to be associated with a high risk of recurrence, poor overall survival (OS), and disease-free survival (DFS) rates. This study evaluated the clincopathological features and survival of non-metastatic TNBC women in the capital of Iran compared with other areas of the world. Methods: In a retrospective study, 119 women with TNBC based ...
متن کاملAn unusual metastatic breast cancer presentation Report of a case
ABSTRACTWe are reporting a 43-year-old female breast cancer case with a solitary metastatic adenocarcinoma in clivus. This patient with a stage II (T1N1M0) breast cancer history has been followed for 7 years. Modified Radical Mastectomy (MRM) and 6 courses chemotherapy with CMF (Cyclophosphamide, Metotrexate, 5FU) regimen were done for her at the time of diagnosis. Also, she took tamoxifen tw...
متن کاملBevacizumab for Metastatic Breast Cancer
Breast cancer is the most common cancer among women; it also contributes to a substantial proportion of the global cancer burden1. At diagnosis, metastatic breast cancer (mbca) accounts for 5%–10% of all breast cancers2. Molecular subtyping is essential when choosing a treatment for mbca. The most commonly used biomarkers of treatment response are the estrogen and progesterone hormone receptors...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Global Oncology
سال: 2018
ISSN: 2378-9506
DOI: 10.1200/jgo.18.18400